Alicia Barroso

Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

José Palacios, Emiliano Honrado, Ana Osório et al. · PubMed · 2003 · 175 citations

Medicine, Genetics, Oncology +17

Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers

Jos� Palacios, Emiliano Honrado, Ana Osório et al. · Breast Cancer Research and Treatment · 2005 · 165 citations

Medicine, Oncology, Pathology +17

Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families

María J. García, María Victoria Fernández, Ana Osório et al. · Breast Cancer Research and Treatment · 2008 · 102 citations

Life Sciences, Genetics, Molecular Genetics +11

A Predictor Based on the Somatic Genomic Changes of the BRCA1/BRCA2 Breast Cancer Tumors Identifies the Non-BRCA1/BRCA2 Tumors with BRCA1 Promoter Hypermethylation

Sara Álvarez, Ramón Díaz‐Uriarte, Ana Osório et al. · Clinical Cancer Research · 2005 · 78 citations · Full text

Medicine, Genetics, Oncology +17

Characterization of the Cancer Spectrum in Men With Germline<i>BRCA1</i>and<i>BRCA2</i>Pathogenic Variants

Valentina Silvestri, Goska Leslie, Daniel R. Barnes et al. · JAMA Oncology · 2020 · 67 citations · Full text

Medicine, Genetics, Oncology +17